foxo4-dri senolytic peptide baar 2017 cell Computational design of targeting FOXO4. a, Domains of FOXO4 Molecular modelling of the FOXO4-TP53
Description
Any cloudiness or particles indicate a problem, and the vial should not be used
If another two weeks go smoothly, consider whether results warrant increasing concentration or maintaining the current level
Vial Format Supplied lyophilized in 50mg and 100mg strengths
10.1371/journal.pone.0153187 PLoS One 18 ChanK
doi: 10.1038/s41598-024-60919-5 52
